INTRODUCTION
Systemic sclerosis (SSc) is characterized by small vessel vasculopathy, production of autoantibodies and fibroblast dysfunction increasing the deposition of extracellular matrix. 1 Interstitial lung disease (ILD) is a common complication of SSc with a reported prevalence of 25-90% according to a previous review, 2 and it is evidently associated with an increased risk of death. 3 In previous studies, baseline forced vital capacity (FVC) and diffusion capacity for carbon monoxide (DL CO ) levels were reported to predict mortality in SScassociated ILD (SSc-ILD), [4] [5] [6] whereas, by highresolution computed tomography (HRCT) examination, SSc-ILD frequently shows one of the two phenotypes: usual interstitial pneumonia (UIP) or fibrotic nonspecific interstitial pneumonia. 4 HRCT examination is reproducible and objective, and where available it would constitute an effective tool to define accurate management. However, the relationship between these patterns (with or without histopathological examinations) and mortality remains controversial. 4, 6 In the context of idiopathic fibrotic lung disease, several studies have reported prognostic HRCT findings, and that a radiographic fibrosis score based on the extent of reticulation and honeycombing on HRCT scanning predicted mortality. 7, 8 The advantage of this approach is that prognosis may be predicted without classification of HRCT patterns.
In this study, we retrospectively analysed patients with SSc-ILD to evaluate whether radiographic fibrosis score was a useful predictor of mortality.
SUMMARY AT A GLANCE
It is unknown whether radiographic fibrosis score predicts mortality in systemic sclerosis-associated interstitial lung disease. This study shows that a high radiographic fibrosis score was a poor prognostic factor. More widespread fibrosis was associated with an increased risk of death, independent of high-resolution computed tomography pattern.
METHODS

Patients
This retrospective study was conducted at Kurashiki Central Hospital in Japan, and was approved by the Ethics Committee of Kurashiki Central Hospital in accordance with the Declaration of Helsinki (approval number 2257). All patients with a rheumatologistconfirmed diagnosis of SSc and HRCT evidence of ILD between January 2006 and April 2016 at our hospital were included. The diagnosis of SSc was based on the criteria established by the American College of Rheumatology and the European League against Rheumatism described in 2013. 9 The first visit to our hospital was used as their date of diagnosis.
Radiology
Each patient's HRCT patterns were independently reviewed by three expert pulmonologists and one expert radiologist and all disagreements were resolved through consensus. On the other hand, we calculated the disease extents together by manually tracing around the area of HRCT findings and there was little difference in the tracing area. All HRCT examinations were conducted via a 3D Ziostation2 PLUS Imaging Workstation (Ver2.4) (Ziosoft Inc., Tokyo, Japan), and images were analysed in a random order by observers who were blinded to clinical and lung function information. The images and parenchymal patterns were examined with reference to a previous report on connective tissue disease in ILD and the Fleischner Society's glossary of terms for thoracic imaging with minor modifications. 6, 7, 10 Six anatomical levels were chosen, as follows: (i) the arch of the aorta; (ii) the carina; (iii) the pulmonary venous confluence; (iv) a point halfway between level 3 and level 5; (v) 1 cm above the dome of the right hemidiaphragm; and (vi) 2 cm below the dome of the right hemidiaphragm. The images were scored as follows: 1. At each of the six section levels, the area of fibrosis, ground-glass opacity (GGO), consolidation and all lung parenchyma were calculated by manually tracing around each area (Fig. 1) . The percentage ratio of each individual parenchymal pattern area to the total lung parenchymal area was calculated. 2. For each parenchymal pattern, the scores (expressed as a percentage) in each of the six sections were summed. The mean score for the six levels was defined as the final score. 3. Traction bronchiectasis (TBE) was scored in each of the six sections as 0 = none; 1 = mild; 2 = moderate; or 3 = severe, based on the most severely affected airways. The mean of the TBE scores for the six levels was defined as the final TBE score. 4. HRCT scans were classified as depicting a definite or possible UIP pattern, or inconsistent with a UIP pattern according to the guidelines established by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society and the Latin American Thoracic Association described in 2011.
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The parenchymal patterns and TBE score are shown in Appendix S1 (Supplementary Information).
Clinical data
Clinical characteristics were ascertained from the available clinical records. Overall survival (OS) was measured from the date of the diagnosis of SSc-ILD until the date of death from any cause, or until the date of the final medical examination or on which the patient was last confirmed to be alive via the telephone. Only one patient could not be confirmed survival, and it was censored. Pulmonary hypertension was defined as mean pulmonary artery pressure > 25 mm Hg at rest as determined by right-sided cardiac catheterization, or estimated right ventricular systolic pressure > 50 mm Hg determined via echocardiogram (in the absence of right-sided cardiac catheterization). Pulmonary artery diameter was measured at the level of the pulmonary artery bifurcation, and the ascending aorta diameter was averaged from two perpendicular measurements taken from the same CT image as previously reported. 12 Chronic kidney disease was defined as an estimated glomerular filtration rate < 60 mL/min/1.73 m 2 using the Chronic Kidney Disease Epidemiology Collaboration equation and/or evidence of kidney damage for at least 3 months. The kidney damage was defined by structural abnormalities or functional abnormalities other than decreased glomerular filtration rate. 13 Gastro-oesophageal reflux disease was diagnosed via the upper gastrointestinal endoscopy test.
Statistical analysis
We used the log-rank test to compare and the KaplanMeier method to display survival curves for the cohort stratified by HRCT pattern. Univariate and multivariate prognostic analyses were performed for OS using the Cox proportional hazards model. For multivariate survival analysis, a stepwise backward procedure to derive a final model of the variables that had a significant independent relationship with OS was employed. All variables with a P-value of < 0.05 in the univariate analyses were entered into the multivariate analysis. Receiver operating characteristic (ROC) curve analysis was used to determine the optimal radiographic fibrosis cut-off scores for the prediction of death, where values with maximum joint sensitivity and specificity were selected. ROC curve analysis included death and censored data for the end of observation period. Spearman's rank correlation coefficient was used to examine the relationships between radiographic fibrosis score and pulmonary physiology. Categorical variables were compared using the Fisher's exact test, and continuous variables were compared using the Mann-Whitney U-test. All statistical analyses were performed using R (The R Foundation for Statistical Computing V.3.3.2, Vienna, Austria). Hazard ratios (HR) and CI were calculated, statistical significance was defined as a P < 0.05 and data were expressed as medians and interquartile ranges.
RESULTS
Patients
Data from 147 patients diagnosed with SSc at our hospital between January 2006 and April 2016 were obtained from the hospital's database. Ninety-nine patients were excluded due to there being no ILD when SSc was diagnosed (n = 89), ILD without HRCT (n = 4), no evaluation with chest imaging (n = 2) or complication involving another collagen vascular disease (n = 4; microscopic polyangiitis = 2, polymyositis = 1, Sjögren's syndrome = 1). Thus, 48 patients were included in this study. The clinical characteristics of the patients are shown in Table 1 , and HRCT distributions, findings and patterns are shown in Table 2 .
Survival
The median follow-up period was 56.6 months, and 15 patients died over the follow-up period. The 5-year survival was 72.4%. The univariate analysis identified factors that were significantly associated with OS including age, being male, chronic kidney disease, radiographic fibrosis score, TBE and FVC (Table 3 ). In the multivariate analysis, age (HR: 1.07, 95% CI: 1.00-1.14, P = 0.046), being male (HR: 5.10, 95% CI: 1.47-17.7, P = 0.01), radiographic fibrosis score (HR: 1.03, 95% CI: 1.00-1.06, P = 0.049) and FVC (HR: 0.95, 95% CI: 0.91-0.99, P = 0.01) were statistically significantly associated with an increased risk of death. As shown in Figure 2 , the 5-year survival was 73.3% in patients with UIP pattern on HRCT and 71.5% in those without UIP pattern. There was no significant difference in OS between patients with and without UIP pattern on HRCT (P = 0.61).
Optimal radiographic fibrosis cut-off values
The ROC curve for radiographic fibrosis score was used to determine cut-off values (Fig. 3) . The area under the curve for radiographic fibrosis score to OS was 0.85 (95% CI: 0.73-0.97) and a radiographic fibrosis score of 14.2% corresponded to the maximum joint sensitivity and specificity on the ROC curve (81.8% sensitivity and 73.3% specificity). Kaplan-Meier analysis was performed to determine whether radiographic fibrosis score was associated with OS. OS was significantly shorter in the group with radiographic fibrosis scores ≥ 14.2% than in the group with scores < 14.2% (P < 0.001) (Fig. S1, Supplementary Information) . We also analysed that the area under the curve shown at 12 monthly intervals for radiographic fibrosis score thresholds of 10%, 14.2%, 20% and 25%. On paired ttesting, areas under the curve values were higher with a threshold of 20% than 14.2% (P < 0.001) or 25% (P = 0.001), and also higher with a threshold of 14.2% than 10% (P = 0.485) (Fig. S2 , Supplementary Information).
Fibrosis score/pulmonary physiology associations
Associations between radiographic fibrosis score and pulmonary physiology are shown in Figure S3 (Supplementary Information). Radiographic fibrosis score was significantly negatively correlated with %pre-dicted FVC (r = −0.43, P = 0.003) and %predicted DL CO (r = −0.34, P = 0.03). Radiographic fibrosis scores were higher in males than in females (Fig. S4 , Supplementary Information).
DISCUSSION
We analysed patients with SSc-ILD to evaluate whether radiographic fibrosis score was a useful predictor of mortality. We demonstrated that a high radiographic fibrosis score was a poor prognostic factor in SSc-ILD. Radiographic fibrosis score was a composite score based on the extent of reticulation and honeycombing on HRCT scanning, which has been reported as a poor prognostic factor in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonia. 7, 14 To the best of our knowledge, this is the first report showing the prognostic significance of radiographic fibrosis score in SSc-ILD.
The optimal cut-off value for radiographic fibrosis score to OS was 14.2%, with moderate accuracy. 15 A previous study reported that the extent of disease on HRCT was associated with SSc-ILD, 16 and Moore et al. 17 and Goh et al. 5 showed a threshold of total disease extent of approximately 20%. Our threshold value was lower than those of these previous studies, probably because the total disease extent in those previous studies included not only the extent of reticular disease but also that of GGO. However, GGO may be a good prognostic factor 5 and we considered that GGO was not a parenchymal pattern suggesting fibrosis such as reticular disease. In Figure 1 How to obtain each parenchymal pattern score at each level. The example of radiographic fibrosis score at 2 cm below the dome of the right hemidiaphragm. (A) The area of fibrosis is calculated to be 2380 mm 2 by summing Area (1) and Area (2). Each area was calculated by manually tracing around the each area using 3D Ziostation2 PLUS Imaging Workstation (Ver2.4). (B) The area of all lung parenchymas is calculated to be 12528 mm 2 by summing Area (Rt) and Area (Lt) in the same way. The radiographic fibrosis score at this level is 19% which is obtained by dividing 2380 by 12 528.
order to examine exactly the extent of fibrosis without GGO, we needed to trace the disease extent. Therefore, our method of tracing the extent of fibrosis was exact and highly reproducible. However, it may be too complicated and time-consuming to use in clinical practice. It may be necessary to investigate if similar results are obtained by reducing sections to be evaluated in the future. Development of more convenient software is also required. This method may be helpful to be used for clinical trials and as a springboard for future studies.
We found no significant difference in survival between SSc patients with UIP pattern on HRCT and those without UIP pattern. In multivariate analyses, radiographic fibrosis score and baseline pulmonary function were independent predictors of survival, while HRCT pattern was not. Similarly, a previous study has reported no significant difference in survival between SSc patients with UIP pattern and those without UIP pattern. 4 It has also been previously reported that in rheumatoid arthritis-related ILD patients, baseline pulmonary physiology independently predicted mortality, while HRCT pattern did not. 18 This suggests that SSc-ILD patients with more widespread fibrosis and those with worse pulmonary physiology were at an increased risk of death, independent of their HRCT pattern. The reason why HRCT pattern was not predictive factor in SSc-ILD may be moderate interobserver agreement for diagnosis of UIP and honeycombing. 19, 20 Radiographic fibrosis score was not useful to distinguish between reticulation and honeycombing. Therefore, radiographic fibrosis score was a very useful independent predictor of mortality in SSc-ILD.
Several studies have reported that FVC and DL CO were predictive of mortality in SSc-ILD. 4, 9 In this study, radiographic fibrosis score and pulmonary physiology were not strongly correlated, and FVC was an independent predictor of mortality according to multivariate analysis. Radiographic fibrosis score represented exactly the extent of pulmonary fibrosis, but it did not reflect the quality of the fibrosis. This may be a weak point of radiographic fibrosis score, and the pulmonary physiology may compensate for its drawback. Combined evaluation with HRCT extent and FVC was reported to provide discriminatory prognostic information. 5 This may indicate that FVC had additional prognostic information to the extent of fibrosis on HRCT. However, Goh et al. reported that spirometry has the wide range of normal pulmonary function test values, and therefore baseline FVC levels are likely to be misleading when disease is either minimal or severe. 5 On the other hand, radiographic fibrosis score was objective and universal, because it was directly calculated based on the extent of fibrosis evident on HRCT.
We found that age, being male and FVC were also independent predictors of mortality according to the multivariate analysis, and several previous studies have reported similar results. 4, 21 In one previous study, being male was associated with severe restrictive lung disease 22 and baseline FVC was a predictor of fibrosis outcome. 23 In this study, male patients exhibited higher radiographic fibrosis scores.
It remains unclear which patients with SSc-ILD need treatment. Some progress rapidly, while others remain stable, or their condition may even slowly improve. Careful monitoring of radiographic fibrosis scores may help to identify the early worsening of SSc-ILD. New potential SSc-ILD therapies such as mycophenolate mofetil, rituximab and antifibrotic agents have been proposed. 24, 26 It is important to identify patients at risk of the development and progression of SSc-ILD, in order to facilitate the timely administration of treatment.
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There are limitations to this study. First, it was a single-centre and retrospective study. Therefore, the number of patients who died (n = 15) was too small to perform multivariate analysis. However, we think it was an advantage to be consistent in evaluation of patients' characteristics such as diagnostic process of SSc, interpretation of ILD and the treatment strategies. Second, GGO, ground-glass opacity; PA, pulmonary artery; SSc, systemic sclerosis; SSc-ILD, SSc-associated interstitial lung disease; UIP, usual interstitial pneumonia. Figure 2 Kaplan-Meier analysis of overall survival for patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) (usual interstitial pneumonia (UIP) vs no UIP).
, no UIP pattern on HRCT;
, UIP pattern on HRCT.
we routinely screened for pulmonary hypertension with echocardiogram and only two patients were over 40 mm Hg in right ventricular systolic pressure. Rightsided cardiac catheterization was performed in five patients. However, right-sided cardiac catheterization was not performed in all patients and this may have underestimated pulmonary hypertension. As an additional study, we examined pulmonary arterial diameter and ascending aortic diameter. However, pulmonary artery to ascending aorta diameter ratio > 1 was only 6.3% (n = 3), and was not prognostic factor on OS in univariate analysis (P = 0.79). Finally, bronchoalveolar lavage was only measured in 40% of the patients in this study. We did not examine bronchoalveolar lavage in this study, as we did not consider it to be associated with prognosis.
In conclusion, a high radiographic fibrosis score was a poor prognostic factor in SSc-ILD. More widespread fibrosis increased the risk of death, independent of HRCT pattern.
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